Skip to main content
Protagonist Therapeutics, Inc logo

Protagonist Therapeutics, Inc — Investor Relations & Filings

Ticker · PTGX ISIN · US74366E1029 US Manufacturing
Filings indexed 641 across all filing types
Latest filing 2019-12-03 Regulatory Filings
Country US United States of America
Listing US PTGX

About Protagonist Therapeutics, Inc

https://www.protagonist-inc.com/

Protagonist Therapeutics, Inc. is a clinical-stage biopharmaceutical company that specializes in the discovery and development of peptide-based new chemical entities. The company utilizes its proprietary technology platform to engineer novel oral and injectable peptide therapeutics. Its development pipeline is focused on creating treatments for rare and prevalent diseases, particularly in the areas of hematology and gastroenterology, addressing significant unmet medical needs.

Recent filings

Filing Released Lang Actions
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated December 3, 2019, by Protagonist Therapeutics, Inc. It announces preliminary Phase 2 clinical trial results and includes a press release as an exhibit. The document also mentions a conference call to discuss these results. There are no detailed financial statements or comprehensive financial analysis included. The document is a current report disclosing material events rather than a full financial report or earnings release. Given the nature of the content and the form type, this filing is best classified as a Regulatory Filing (RNS), which serves as a general category for miscellaneous SEC filings that do not fit other specific categories.
2019-12-03 English
8-K
Capital/Financing Update Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated November 27, 2019, by Protagonist Therapeutics, Inc. It announces the entry into a material definitive agreement with Jefferies LLC for an Open Market Sale Agreement to sell up to $75 million of common stock. The document includes details about the agreement, commission, and termination conditions. It does not contain financial statements or quarterly/annual financial results but is an announcement of a financing arrangement. This fits the definition of a Capital/Financing Update (CAP). The document length is 5761 characters, which is sufficient to contain substantive information about the financing agreement rather than just a brief announcement or a report publication notice.
2019-11-27 English
424B5
Capital/Financing Update Classification · 95% confidence The document is a 'Prospectus Supplement' filed pursuant to Rule 424(b)(5) related to a securities offering. It discusses the terms of an offering of common stock, the sales agreement with Jefferies LLC, and includes sections such as 'Risk Factors', 'Use of Proceeds', and 'Plan of Distribution'. It is not a financial report, earnings release, or management discussion. It is a detailed disclosure document related to capital raising activities. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is substantial (15,000 characters), indicating it is the actual prospectus supplement, not just an announcement of a report. Hence, the classification is CAP with high confidence.
2019-11-27 English
FORM 4 SUBMISSION
Director's Dealing
2019-11-27 English
Regulatory Filings 2019
Regulatory Filings
2019-11-25 English
Regulatory Filings 2019
Regulatory Filings Classification · 90% confidence The provided document text appears to be encoded or encrypted and does not contain any readable content, keywords, regulatory headers, or references to specific report types, fiscal periods, or regulatory bodies. Due to the lack of discernible information and the inability to identify the document's nature, it cannot be classified into any specific filing category based on the given text. According to the rules, when a document does not neatly fit into any specific category, it should be classified as a Regulatory Filing (RNS), which serves as a fallback category.
2019-11-21 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.